Business Wire

One Banana Presents Its Sustainability Report 2020

Share

One Banana, the better banana Co., presents its seventh Corporate Sustainability Report reflecting on the achievements and execution of its Sustainability Strategy amid a life-changing year in 2020.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210721005928/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Amid a life-changing year, One Banana presents its 7th Corporate Sustainability Report reflecting on the achievements made in the execution of its Sustainability Strategy in 2020. With new projects and continuing existing ones, One Banana aims to promote the well-being of customers, workers, their families, and communities through continuous improvement, environmental conservation, education, health and nutrition projects, among others. (Photo: Business Wire)

"We have taken more time, effort, and resources to prepare and publish our sustainability report due to the implementation of new methodologies to better measure and present how we create sustainable value," said Javier Aguirre, Corporate Director of AgroAmerica. "In this challenging year, we updated the pillars of our Corporate Sustainability Strategy to align business priorities and the changing expectations of our stakeholders."

One Banana and One Banana Ingredients are the brands under which AgroAmerica commercializes bananas and natural ingredients. This year, the corporation consolidated the banana ingredients business, reducing waste to a minimum and offering its customers a new range of sustainable food.

Some outstanding achievements are:

  • 186 million bananas transformed into food ingredients under the principle of zero waste.
  • Employment generation for 12,537 direct and indirect positions, promoting gender equality and growth opportunities for employees, their families, and communities.
  • Responsible use of natural resources through investment in technology that allows a reduction of up to 50% in water use compared to traditional irrigation technologies.
  • 11 international certifications, supporting the statement: We strive to achieve sustainable production every day.
  • Unprecedented efforts to address the COVID-19 pandemic and extraordinary response to two hurricanes in the Central American region.
  • Continuity of existing projects regarding environmental conservation, education, health and nutrition, among other projects to promote the well-being of workers, their families, and communities in the area of influence, as well as support for community management activities.

“We are pleased to present our Sustainability Report to our customers, suppliers, certifying entities, and the general public,” said Fernando Bolaños, CEO of AgroAmerica. “It reflects our commitment to do responsible business and align our corporate management with the Sustainable Development Goals while complying with the Communication on Progress (CoP) before the United Nations Global Compact, an entity of which we have been a signatory since 2020.”

This report reaffirms the corporation’s commitment to producing food and ingredients responsibly and sustainably.

"Our report notes the progress we have made and sets our expectations for the future," said Robert Adams, President of One Banana. "allowing One Banana to be the better banana Co.”,

View full report here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Javier Aguirre
Corporate Director
sustainability@agroamerica.com
(502) 2420-9600

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

HiddenA line styled icon from Orion Icon Library.Eye